Skip to main content

Actym Therapeutics, Inc.

Berkeley, United States

Actym Therapeutics is a biotech company that focuses on the discovery and development of novel immuno-oncology therapies to treat cancer.

$25.5M raised
Oct 2023
Series A

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Actym Therapeutics, Inc.

How much funding has Actym Therapeutics, Inc. raised?
Actym Therapeutics, Inc. has raised $25.5M in total funding. The most recent round was Series A. The last funding was announced in October 2023.
Who are Actym Therapeutics, Inc.'s investors?
Actym Therapeutics, Inc.'s investors include Illumina Ventures, Boehringer Ingelheim Venture Fund, Korea Investment Partners, Panacea Venture, Intellectus Partners.
Where is Actym Therapeutics, Inc. headquartered?
Actym Therapeutics, Inc. is headquartered in Berkeley, United States.
What does Actym Therapeutics, Inc. do?
Actym Therapeutics is a biotech company that focuses on the discovery and development of novel immuno-oncology therapies to treat cancer.
What stage is Actym Therapeutics, Inc. at?
Actym Therapeutics, Inc. is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Actym Therapeutics, Inc. — Funding & Investors." VCBacked, October 18, 2023, https://www.vcbacked.co/company/actym-therapeutics-inc. Accessed July 2, 2026.
APA
VCBacked. (2023). Actym Therapeutics, Inc. — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/actym-therapeutics-inc
Wikipedia (cite web)
{{cite web |title=Actym Therapeutics, Inc. — Funding & Investors |url=https://www.vcbacked.co/company/actym-therapeutics-inc |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .